Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,015 | -161,354 | -132,738 | -68,523 | -48,079 |
| Depreciation Amortization | 1,324 | 24,913 | 1,879 | 402 | 120 |
| Income taxes - deferred | -182 | 0 | 0 | -1,837 | N/A |
| Accounts receivable | 4,898 | -809 | -4,380 | N/A | N/A |
| Accounts payable and accrued liabilities | -5,219 | -3,160 | 6,964 | 4,564 | 1,810 |
| Other Working Capital | -2,360 | -2,703 | 9,438 | 865 | 4,252 |
| Other Operating Activity | 13,921 | 46,668 | 18,026 | 9,866 | 7,294 |
| Operating Cash Flow | $-38,633 | $-96,445 | $-100,811 | $-54,663 | $-34,603 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -453 | -1,613 | -1,356 | -1,235 | -232 |
| Net Acquisitions | N/A | 34,186 | -67,122 | -9,647 | N/A |
| Purchase Of Investment | -47,714 | -137,385 | -161,598 | -197,337 | -148,764 |
| Sale Of Investment | 54,554 | 210,491 | 239,443 | 152,527 | 87,093 |
| Investing Cash Flow | $6,387 | $105,679 | $9,367 | $-55,692 | $-61,903 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -137 | -30,523 | -648 | -78 | N/A |
| Common Stock Issued | 7,807 | 207 | 100,782 | 100,464 | 116,826 |
| Other Financing Activity | 10,702 | 0 | 28,127 | 0 | 0 |
| Financing Cash Flow | $18,372 | $-30,316 | $128,261 | $100,386 | $116,826 |
| Beginning Cash Position | 35,937 | 57,019 | 20,202 | 30,171 | 9,851 |
| End Cash Position | 22,063 | 35,937 | 57,019 | 20,202 | 30,171 |
| Net Cash Flow | $-13,874 | $-21,082 | $36,817 | $-9,969 | $20,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,633 | -96,445 | -100,811 | -54,663 | -34,603 |
| Capital Expenditure | -453 | -1,613 | -1,356 | -1,235 | -232 |
| Free Cash Flow | -39,086 | -98,058 | -102,167 | -55,898 | -34,835 |